Literature DB >> 17174216

Acetaminophen and diphenhydramine premedication for allergic and febrile nonhemolytic transfusion reactions: good prophylaxis or bad practice?

Terrence L Geiger1, Scott C Howard.   

Abstract

Febrile nonhemolytic and allergic reactions are the most common transfusion reactions, but usually do not cause significant morbidity. In an attempt to prevent these reactions, US physicians prescribe acetaminophen or diphenhydramine premedication before more than 50% of blood component transfusions. Acetaminophen and diphenhydramine are effective therapies for fever and allergy, respectively, so their use in transfusion has some biologic rationale. However, these medications also have potential toxicity, particularly in ill patients, and in the studies performed to date, they have failed to prevent transfusion reactions. Whether the benefits of routine prophylaxis with acetaminophen and diphenhydramine outweigh their risks and cost requires reexamination, particularly in light of the low reaction rates reported at many institutions even when premedication is not prescribed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17174216      PMCID: PMC1868404          DOI: 10.1016/j.tmrv.2006.09.001

Source DB:  PubMed          Journal:  Transfus Med Rev        ISSN: 0887-7963


  61 in total

1.  Antihistamine effects on actual driving performance in a standard test: a summary of Dutch experience, 1989-94.

Authors:  J F O'Hanlon; J G Ramaekers
Journal:  Allergy       Date:  1995-03       Impact factor: 13.146

2.  The relationship between the duration of platelet storage and the development of transfusion reactions.

Authors:  C B Sarkodee-Adoo; J M Kendall; R Sridhara; E J Lee; C A Schiffer
Journal:  Transfusion       Date:  1998-03       Impact factor: 3.157

Review 3.  Non-infectious complications of transfusion therapy.

Authors:  P L Perrotta; E L Snyder
Journal:  Blood Rev       Date:  2001-06       Impact factor: 8.250

4.  Adverse transfusion reactions associated with a precipitating anti-C4 antibody of anti-Rodgers specificity.

Authors:  P Lambin; P Y Le Pennec; G Hauptmann; O Desaint; B Habibi; C Salmon
Journal:  Vox Sang       Date:  1984       Impact factor: 2.144

5.  Non-haemolytic adverse reaction after transfusion of a blood unit containing penicillin.

Authors:  J Michel; R Sharon
Journal:  Br Med J       Date:  1980-01-19

6.  Febrile reactions to platelet transfusion: the effect of increased interleukin 6 levels in concentrates prepared by the platelet-rich plasma method.

Authors:  L Muylle; E Wouters; M E Peetermans
Journal:  Transfusion       Date:  1996-10       Impact factor: 3.157

Review 7.  The role of the sympathetic nervous system and uncoupling proteins in the thermogenesis induced by 3,4-methylenedioxymethamphetamine.

Authors:  Edward M Mills; Daniel E Rusyniak; Jon E Sprague
Journal:  J Mol Med (Berl)       Date:  2004-11-10       Impact factor: 4.599

8.  Cytokine generation in stored, white cell-reduced, and bacterially contaminated units of red cells.

Authors:  G Stack; L Baril; P Napychank; E L Snyder
Journal:  Transfusion       Date:  1995-03       Impact factor: 3.157

Review 9.  Anaphylactic transfusion reactions.

Authors:  Colleen W Gilstad
Journal:  Curr Opin Hematol       Date:  2003-11       Impact factor: 3.284

10.  Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage.

Authors:  I Federowicz; B B Barrett; J W Andersen; M Urashima; M A Popovsky; K C Anderson
Journal:  Transfusion       Date:  1996-01       Impact factor: 3.157

View more
  18 in total

Review 1.  Shifting ground and gaps in transfusion support of patients with hematological malignancies.

Authors:  Christine Cserti-Gazdewich
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  The prevention of adverse reactions to transfusions in patients with haemoglobinopathies: a proposed algorithm.

Authors:  Francesco Bennardello; Carmelo Fidone; Vincenzo Spadola; Sergio Cabibbo; Simone Travali; Giovanni Garozzo; Agostino Antolino; Giuseppe Tavolino; Cadigia Falla; Pietro Bonomo
Journal:  Blood Transfus       Date:  2013-05-21       Impact factor: 3.443

3.  Transfusion-related adverse events in the Platelet Dose study.

Authors:  Richard M Kaufman; Susan F Assmann; Darrell J Triulzi; Ronald G Strauss; Paul Ness; Suzanne Granger; Sherrill J Slichter
Journal:  Transfusion       Date:  2014-07-28       Impact factor: 3.157

4.  Reactions Induced by Platelet Transfusions.

Authors:  Volker Kiefel
Journal:  Transfus Med Hemother       Date:  2008-09-16       Impact factor: 3.747

5.  The IgE-dependent pathway in allergic transfusion reactions: involvement of donor blood allergens other than plasma proteins.

Authors:  Nobuki Matsuyama; Kazuta Yasui; Etsuko Amakishi; Tomoya Hayashi; Ayumu Kuroishi; Hiroyuki Ishii; Harumichi Matsukura; Yoshihiko Tani; Rika A Furuta; Fumiya Hirayama
Journal:  Int J Hematol       Date:  2015-04-04       Impact factor: 2.490

Review 6.  Fever after maxillofacial surgery: a critical review.

Authors:  Amelia Christabel; Ravi Sharma; R Manikandhan; P Anantanarayanan; N Elavazhagan; Pramod Subash
Journal:  J Maxillofac Oral Surg       Date:  2014-01-14

Review 7.  Scratching the surface of allergic transfusion reactions.

Authors:  William J Savage; Aaron A R Tobian; Jessica H Savage; Robert A Wood; John T Schroeder; Paul M Ness
Journal:  Transfusion       Date:  2012-09-24       Impact factor: 3.157

8.  Quality assessment and transfusion efficacy of buffy coat-derived platelet concentrates washed with platelet additive solution.

Authors:  Hermógenes Fernández-Muñoz; Cristina Castilla-Llorente; Eva M Plaza; Cristina Martínez-Millán; Inmaculada Heras; Pastora Iniesta; María L Amigo; Francisca Ferrer-Marin; María J Candela; María L Lozano; Vicente Vicente; José Rivera
Journal:  Blood Transfus       Date:  2017-04-13       Impact factor: 3.443

Review 9.  Reducing noninfectious risks of blood transfusion.

Authors:  Brian M Gilliss; Mark R Looney; Michael A Gropper
Journal:  Anesthesiology       Date:  2011-09       Impact factor: 7.892

Review 10.  Transfusion immunomodulation--the case for leukoreduced and (perhaps) washed transfusions.

Authors:  Katie L Lannan; Julie Sahler; Sherry L Spinelli; Richard P Phipps; Neil Blumberg
Journal:  Blood Cells Mol Dis       Date:  2012-09-13       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.